What is NDC 25021-301?

25021-301 is the product NDC for adenosine, Adenosine 3 mg/mL injection, listed with the FDA by Sagent Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for adenosine?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

adenosine NDC 25021-301 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-301Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0301Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-301-67	2502103016725021030167	10 SYRINGE in 1 CARTON (25021-301-67) / 2 mL in 1 SYRINGEMarketed from Apr 16, 2014
25021-301-68	2502103016825021030168	10 SYRINGE in 1 CARTON (25021-301-68) / 4 mL in 1 SYRINGEMarketed from Apr 16, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): adenosine
Generic name (nonproprietary): adenosine
Active ingredients: Adenosine — 3 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Sagent PharmaceuticalsNDC labeler code 25021
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077283
Marketing start: Apr 16, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Adenosine Receptor Agonists (Mechanism)
Identifiers: Product ID 25021-301_a40e7fe9-478d-4916-9657-5eba074215f0SPL ID a40e7fe9-478d-4916-9657-5eba074215f0SPL set ID 5a55b45d-9cee-4c0c-9e44-021dbf70a018RxCUI 727355, 727360UNII K72T3FS567UPC 0325021301685, 0325021301678
Pharmacologic class: Adenosine Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021030167 followed by a unit qualifier and the quantity

Package 25021-0301-67. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 4, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Adenosine Injection, USP is indicated for the following: Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine administration. It is important to be sure the adenosine solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION ). Adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or atrial fibrillation, a transient modest…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 25021-301

What is NDC 25021-301?: 25021-301 is the product NDC for adenosine, Adenosine 3 mg/mL injection, listed with the FDA by Sagent Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: adenosine.
What is the active ingredient?: Adenosine.
Who is the labeler?: Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for adenosine?: 28 other product NDCs are listed under this name. See all adenosine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other adenosine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-207	71288-0207-21
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-208	71288-0208-30
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	REMEDYREPACK INC.	70518-4207	70518-4207-0070518-4207-02
Adenosineadenosine injection, solution	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9993	00404-9993-02
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1632	51662-1632-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1631	51662-1631-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Sagent Pharmaceuticals	25021-318	25021-0318-0225021-0318-04
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7335	71872-7335-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	ProPharma Distribution	84549-318	84549-0318-02
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	NorthStar Rx LLC	16714-556	16714-0556-01

All 29 adenosine NDCs

Other NDCs under ANDA 077283

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077283
Product	Strength	Form · route	Labeler	Product NDC
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1511
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Gland Pharma Limited	68083-101
adenosine	Adenosine 3 mg/mL	InjectionIntravenous	ProPharma Distribution	84549-031